Skip to main content
logo
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,942.90
-11.10 (-0.57%)
Jul 24, 2026, 3:30 PM IST

NSE:SUNPHARMA Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
584,620584,620525,784484,969438,857386,545
Revenue Growth
11.19%11.19%8.42%10.51%13.53%15.39%
Gross Profit
459,834459,834410,200370,547325,670277,784
Operating Income
136,116136,116126,055105,20293,05881,560
Net Income
114,794114,794109,29095,76484,73632,727
Earnings Per Share
47.8047.8045.5539.9035.3013.60
EPS Growth
4.94%4.94%14.16%13.03%159.56%12.40%

Revenue by Segment
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
India Formulations
192,904192,904169,230148,893136,031127,593
US Formulations
168,242168,242162,403153,493135,353113,737
Emerging Markets
111,865111,86594,16086,19578,97767,432
Rest of the World Formulations
85,68485,68471,62667,12860,42654,545
Active Pharmaceutical Ingredients (API)
21,85321,85321,29219,18719,72418,354
Other Segment
1,6541,6541,7022,6902,2792,604
Other Operating
2,4192,4195,3727,3846,0682,281

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
335,166335,166261,227190,901151,300126,548
Total Debt
46,27346,27323,62232,73768,85912,903
Net Cash (Debt)
288,893288,893237,605158,16482,441113,645
Net Cash Growth
21.58%21.58%50.23%91.85%-27.46%99.57%
Net Cash Per Share
120.41120.4199.0365.9234.3647.37

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
124,192124,192140,721121,35049,59389,845
Capital Expenditures
-36,094-36,094-21,286-22,018-20,856-14,950
Free Cash Flow
88,09888,098119,43599,33228,73874,895
Free Cash Flow Growth
-26.24%-26.24%20.24%245.65%-61.63%49.78%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
78.66%78.66%78.02%76.41%74.21%71.86%
Operating Margin
23.28%23.28%23.97%21.69%21.20%21.10%
Pretax Margin
25.77%25.77%26.13%22.78%21.33%11.55%
Profit Margin
19.64%19.64%20.79%19.75%19.31%8.47%
FCF Margin
15.07%15.07%22.72%20.48%6.55%19.38%

Dividends
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
16.00016.00016.00013.50011.50010.000
Dividend Per Share Growth
0%0%18.52%17.39%15.00%33.33%
Dividend Yield
0.82%0.91%0.93%0.85%1.21%1.14%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
40.6136.7338.0840.6027.8467.06
Forward PE
35.3934.4235.8042.3628.9728.54
P/FCF Ratio
52.8747.8634.8539.1482.0829.30
PS Ratio
7.977.217.928.025.385.68